Adverse Events (No.) (%) | FPO | FPEC | VP |
---|---|---|---|
Transient | |||
Palpebral edema/hyperemia, 55 (55.6%) | 40 | 6 | 9 |
Frontal edema/hyperemia, 14 (14.1%) | 10 | 1 | 3 |
Retinal bleeding, 12 (12.1%) | 10 | 0 | 2 |
Anterior ischemia of the optic nerve, 2 (2%) | 1 | 0 | 1 |
Madarosis, 2 (2%) | 2 | 0 | 0 |
Frontal alopecia, 2 (2%) | 1 | 0 | 1 |
Orbital cellulitis, 1 (1%) | 1 | 0 | 0 |
Glaucoma, 1 (1%) | 0 | 0 | 1 |
Roth spots, 1 (1%) | 1 | 0 | 0 |
Iridocyclitis, 1 (1%) | 1 | 0 | 0 |
Permanent | |||
Chorioretinic atrophy, 16 (16.2%) | 13 | 2 | 1 |
Exotropia, 4 (4%) | 2 | 2 | 0 |
Ptosis, 1 (1%) | 1 | 0 | 0 |
Anisocoria, 1 (1%) | 0 | 0 | 1 |
Cutaneous scar necrosis, 1 (1%) | 0 | 1 | 0 |
Iris heterochromia, 1 (1%) | 0 | 0 | 1 |